Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine A2A Receptors as Biomarkers of Brain Diseases
Ana Moreira-de-Sá, Vanessa S. Lourenço, Paula M. Canas, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 24

Showing 24 citing articles:

Adenosine-A2A Receptor Pathway in Cancer Immunotherapy
Changfa Sun, Bochu Wang, Shilei Hao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Astrocyte regulation of synaptic signaling in psychiatric disorders
Anna Kruyer, Peter W. Kalivas, Michael D. Scofield
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 21-36
Open Access | Times Cited: 53
Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula
Muran Wang, Peijun Li, Zewen Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Glia-derived adenosine in the ventral hippocampus drives pain-related anxiodepression in a mouse model resembling trigeminal neuralgia
Xue‐Jing Lv, Su‐Su Lv, Guohong Wang, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 224-241
Closed Access | Times Cited: 9
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 24, pp. 4138-4151
Open Access | Times Cited: 28
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2680-2680
Open Access | Times Cited: 22
Comparing adenosine A2A receptor modulation of cannabinoid CB1 receptor‐mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals
Samira G. Ferreira, Rafael Mariano de Bitencourt, Pedro Garção, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 1
Closed Access
Macamides as Potential Therapeutic Agents in Neurological Disorders
Karin J. Vera-López, Gonzalo Dávila-Del-Carpio, Rita Nieto-Montesinos
Neurology International (2024) Vol. 16, Iss. 6, pp. 1611-1625
Open Access | Times Cited: 3
Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation
Md. Mominur Rahman, Md. Rezaul Islam, Sadia Afsana Mim, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 10
The adenosine A2A receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling
Rafael Franco, Gemma Navarro, Eva Martínez‐Pinilla
International review of neurobiology (2023), pp. 49-71
Closed Access | Times Cited: 4
Adenosine A2A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ1–42 to Model Early Alzheimer’s Disease
Cátia R. Lopes, António C. Silva, Henrique B. Silva, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 4
Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor
Linya Wang, Pankaj Garg, Kara Y. Chan, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0301223-e0301223
Open Access | Times Cited: 1
Upregulation of adenosine A2A receptor by astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficits.
David Blum, Agathe Launay, Kévin Carvalho, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Purinergic-associated immune responses in neurodegenerative diseases
Sara Carracedo, Agathe Launay, Paul-Alexandre Déchelle-Marquet, et al.
Progress in Neurobiology (2024) Vol. 243, pp. 102693-102693
Open Access | Times Cited: 1
Molecular mechanisms for the prevention and promoting the recovery from ischemic stroke by nutraceutical laminarin: A comparative transcriptomic approach
Jiefeng Luo, Dingzhi Chen, Biyun Qin, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 5
Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy
Nan-Rui Shi, Qi Wang, Jie Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Anti-inflammatory potency of novel ecto-5′-nucleotidase/CD73 inhibitors in astrocyte culture model of neuroinflammation
Katarina Mihajlović, Marija Adžić, Milorad Dragić, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175943-175943
Closed Access | Times Cited: 2
Disruption of CD73-Derived and Equilibrative Nucleoside Transporter 1–Mediated Adenosine Signaling Exacerbates Oxygen-Induced Retinopathy
Shuya Zhang, Bo Li, Lingyun Tang, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 11, pp. 1633-1646
Open Access | Times Cited: 3
The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases
Rafael Franco, Alejandro Lillo, Gemma Navarro, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 9, pp. 791-800
Closed Access | Times Cited: 3
Instituto de pesquisa café e saúde: Prevenção de doenças e melhora da qualidade de vida
Rodrigo A. Cunha, Francieli Rohden, Diogo O. Souza
Research Society and Development (2024) Vol. 13, Iss. 5, pp. e1513545666-e1513545666
Open Access
Effect of curcumin–donepezil combination on spatial memory, astrocyte activation, and cholinesterase expressions in brain of scopolamine-treated rats
Opeyemi B. Ogunsuyi, Omodesola Oluwafisayo Ogunruku, Haruna Isiyaku Umar, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease
Milica Zeljković, Jelena Stanojević, Ivana Stevanović, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 2053-2067
Open Access
Adenosine signaling: a potential therapeutic target for psychogenic erectile dysfunction
Kaiyang Xue, Mingxi Yan, Zhu Zhou, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 12, pp. 7248-7261
Closed Access
Effects of chronic caffeine intake and withdrawal on neural activity assessed via resting-state functional magnetic resonance imaging in mice
Mitsuki Rikitake, Sachiko Notake, Karen Kurokawa, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11714-e11714
Open Access | Times Cited: 2
Page 1

Scroll to top